Piper Jaffray Updates On ILMN

Piper Jaffray has issued a report updating on Illumina Inc ILMN following meetings in Hong Kong. According to the report, "On the last day of our 5th Annual China Fieldtrip, we visited BGI Hong Kong, who is in the process of adding additional HiSeq's to their 82 current instruments. Importantly, it appears Illumina has also fixed their relatively recent flow cell issue by changing vendors. Looking ahead, we suspect Illumina have the inside track should BGI expand beyond their existing order." ILMN has an Overweight Rating and closed Friday at $70.76 a share.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsHealth CareLife Sciences Tools & ServicesPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!